Items where Author is "Hartmann, Wolfgang"
 | Up a level |
Article
Fischer-Riepe, Lena and Kailayangiri, Sareetha and Zimmermann, Katharina and Pfeifer, Rita and Aigner, Michael and Altvater, Bianca and Kretschmann, Sascha and Voelkl, Simon and Hartley, Jordan and Dreger, Celine and Petry, Katja and Bosio, Andreas and von Doellen, Angelika and Hartmann, Wolfgang and Lode, Holger and Goerlich, Dennis and Mackensen, Andreas and Jungblut, Melanie and Schambach, Axel and Abken, Hinrich and Rossig, Claudia (2024) Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. CLINICAL CANCER RESEARCH, 30 (16). pp. 3564-3577. ISSN 1078-0432, 1557-3265
Altvater, Bianca and Kailayangiri, Sareetha and Spurny, Christian and Fluegge, Maike and Meltzer, Jutta and Greune, Lea and Urban, Katja and Schwoeppe, Christian and Brand, Caroline and Schliemann, Christoph and Hintelmann, Heike and Harrach, Saliha and Hartmann, Wolfgang and Abken, Hinrich and Kuehle, Johannes and Schambach, Axel and Goerlich, Dennis and Berdel, Wolfgang E. and Rossig, Claudia (2023) CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. CANCER GENE THERAPY, 30 (10). pp. 1355-1368. ISSN 0929-1903, 1476-5500
Schulze, Arik Bernard and Wenge, Daniela Vanessa and Evers, Georg and Heitkoetter, Birthe and Bleckmann, Annalen and Schmidt, Lars Henning and Mohr, Michael and Hartmann, Wolfgang and Arteaga, Maria Francisca and Mikesch, Jan-Henrik (2023) High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts. TRANSLATIONAL LUNG CANCER RESEARCH, 12 (4). ISSN 2218-6751, 2226-4477
Schulze, Arik Bernard and Kuntze, Anna and Schmidt, Lars Henning and Mohr, Michael and Marra, Alessandro and Hillejan, Ludger and Schulz, Christian and Goerlich, Dennis and Hartmann, Wolfgang and Bleckmann, Annalen and Evers, Georg (2022) High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma. CANCERS, 14 (6): 1395. ISSN , 2072-6694
